TranS1 appoints Brandon Arthurs as new VP of research & development: 4 things to know

TranS1, a Denver-based device company offering spinal pathology treatment products, appointed Brandon Arthurs its new vice president of research and development.

Advertisement

Here are four things to know:

 

1. Mr. Arthurs will head collaborations with surgeons and entrepreneurs to present new devices to the market.

 

2. He will also work with the company’s surgeon advisory board to head physician-driven innovation and research.

 

3. Mr. Arthurs previously worked for TranS1 as director of research and development, an engineering manager and senior R&D engineer.

 

4. He also served as project engineer for the Wrightsville Consulting Group.

 

“Brandon’s prior experience with the TranS1 brand and its products, coupled with extensive relationships with surgeons, make him a huge asset,” said Jeff Schell, CEO, TransS1.

 

More articles on devices:
Analysts weigh in on Stryker shares — Is there an opportunity for growth through 2016?
Needham & Company gives Mazor Robotics’ shares ‘hold’ rating — 5 facts
McGinley Orthopedics receives recognition for medical device — 3 highlights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.